Trial Profile
A Randomized, Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of HL-009 Liposomal Gel in Adult Patients With Mild to Moderate Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2015
Price :
$35
*
At a glance
- Drugs Cobamamide (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors HanAll Biopharma
- 03 Mar 2014 New trial record